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PSI.12 P55. Substance related disorders - other 
Endogenous ethanol and microbe associations at patients with 
alcoholic dependence 
N. Perminova’ *, M. Chuhrova2, I. Timofeyev’. ‘Stare Research 
Center of virology & Biotechnology “Vector”: 21nstitute of Internal 
Thempy, SB RAMS, Russia 
P55.01 
Addiction, stigma and the movies 
G. Cape’. University of Otago, Department of Psychological 
Medicine, Dunedin, New Zealand 
Systematic usage of alcohol results in predominance of lipid 
metabolism in comparison with carbohydrate metabolism. Synthe- 
sis of endogenous ethanol is decreased. This is not the only cause 
of decreasing of endogenous ethanol synthesis. We found that pa- 
tients suffering from alcoholism have essentially disturbed microbe 
ensembles in bowels. This dysbacteriosis not only disturbs their 
immune reactivity, results in deficiency in vitamins, aminoacids and 
other biologically active compounds, but also deprives organism of 
endogenous ethanol synthesized by some symbiotic microorgan- 
isms. Alcoholic dysbacteriosis indirectly causes appearance offer- 
mentative pathology - decreasing of cycle Crebs enzymes activity 
that aggravates suppression of carbohydrate metabolism. Treatment 
of patients suffering from alcoholic dependence with probiotics 
such as bifidumbacterine and lactobacterine is insufficiently ef- 
fective. We obtained combined bacterial preparation containing 
immobilized on the activated charcoal microbe association. These 
microorganisms consecutively enter into vital functions resulting 
in marked positive changes. Patients noted decreasing of need for 
alcohol. The level of endogenous ethanol in the blood increased, 
content of glucose and lipids, activities of lactate dehydrogenase, 
pyruvate kinase, aldehyde dehydrogenase, oxydoreductases normal- 
ized, activity of transferases decreased. 
Social cognitions and attitudes about alcohol and drug use develop 
through direct experience and from the experience of others, and 
some conveyed through exposure to indirect socialising agents: 
books, magazines, advertisements and not least.. movies. Some 
writers take this further by saying that movies, due to their 
enormous power of engagement, make history and dictate societal 
norms and values. I wish to explore some of the stereotypes of 
addiction using excerpts from mainstream movies and arrive at a 
framework for understanding their impact on the audience’s world 
view. Since the 1920’s cinema has, for better or worse, shaped 
society’s view about drug and alcohol use and misuse. I have 
attempted to typify the alcohol and drug using movie character(s) 
according to stereotypes. I further assert that stigmatisation of the 
alcohol or drug user is influenced enormously through this form 
of communication. 20 film clips. 
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Population survey of drug abusers attending a Swiss detoxification 
unit 
S.L. Krenz’, D.F. Zullino, G. Zimmermann, B. Favrad, C. Eichen- 
berger, S. Die&man, J. Besson. H6pital de Cery, Division d’Abus 
de Substances, Prilly-Lausanne, Switzerland 
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Efficacy of oxcarbazepin in alcohol relapse prevention - 
a pilot study 
The main characteristics of patients admitted for inpatient detoxi- 
fication in an University based substance abuse unit were assessed. 
B. Croissant l , T. Scherle, A. Heinz, K. Mann. University of Heidel- 
berg Department of Addictive Behavior and Addiction Medicine, 
Central Institute of Mental Health, Mannheim, Germany 
Methods: A short questionnaire was applied, investigating so- 
ciodemographic data, patterns of drug/alcohol consumption, previ- 
ous treatments, outcome and therapeutics projects. 
Introduction: The anticonvulsant carbamazepine is used in alcohol 
withdrawal. It also reduced the relapse risk in a double-blind 
pilot study with 29 patients (Autor et al 192~). However, its 
use in alcoholics is often limited because of its metabolism in 
the liver and hepatic impairment in alcoholism. This problem 
could be addressed by the use of the carbamazepine-derivative 
oxcarbazepin, because unlike carbamazepine it is only metabolized 
by specific isoenzymes of the cytochrome P-450 3A group. No 
epoxide emerges in the metabolism, which explaines the better 
tolerability of oxcarbazepine. 
Results: The mean age of the 550 patients admitted during the 
3-year observation period was 29.5f6.5 years. 36,5% were referred 
by GP’s and 62.2% by professionals of the regional addiction 
network. 86,4% were polysubstance abusers, the main substance 
class being opiates. The mean drug abuse history was 9.1 years 
and 92.2% of the patients had previous withdrawal experiences, 
19,1% of them in our unit. Whereas 56,5% planned to enter a 
therapeutic community after detoxification, only 29,3% actually 
maintained their initial project. No secular trends were identified 
over the 3 year observation period. Methadone therapy or previous 
withdrawal experience had no impact on outcome. 
Methods: We evaluated oxcarbazepine for relapse prevention in 
ten high risk patients, who had repeatedly (mean 5 times in about 
10 years of dependence) relapsed after detoxification and who had 
also failed to respond to acamprosate. Patients were seen weekly in 
our out-patient clinic after detoxification and received about 900mg 
oxcarbazepine per day. All Patients fulfilled ICD-10 criteria for 
alcoholism and suffered from no other psychiatric disorder. 
Conclusions: High level of care drug abuse programs not only 
reaches a wide range of patients, but may show good treatment 
outcome independent of patients profile. 
P55.03 
Results: Ten patients were treated, the overall tolerability was 
good. Four patients remained abstinent for at least 15 weeks (mean 
20 weeks) under treatment, while treatment had to be terminated 
in four patients due to side effects, mainly an allergic skin reaction 
in three patients. ?kro more patients relapsed under oxcarbazepin 
medication. 
Topiramate in multidrug withdrawal - comparison with clonidine 
S.L. Krenz, G. Zimmermann, M. Pin, S. Kolly, J. Besson, 
D. Zullino. Hbpital de Cety, Division diibus de Substances, 
Dipartement Universitaire de Psychiatric Adulte, Prilly-Lausanne, 
Switzerland 
Conclusion: Altogether, oxcarbazepin might w-t tier 
investigation and may be useful in preventing alcohol relapse in 
some previously treatment-resistant alcoholics. 
The pharmacological profile of topiramate suggests it could be 
rather valuable for opiate withdrawal. In fact, there is some ev- 
idence that topiramate acts, among others, through inhibition of 
a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) 
receptors, which play an important role in the withdrawal-induced 
activation of the locus coeruleus (LC) by glutamate. 
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Methods: Ten multidrug detoxification inpatients treated with 
a topiramate-protocol were compared to 10 patients treated with 
a clonidine-scheme and 10 patients treated with a carbamazepine- 
mianserine protocol. Comedication, protocol deviations (dose aug- 
mentation or reduction) and retention in treatment were compared 
between groups. 
Results: There were significantly less protocol deviations in the 
topiramate group compared to the other two groups. Topiramate 
treated patients were less often given antiemetics and sedative 
antipsychotic drugs. The retention in treatment was comparable 
between the 3 groups. 
Conclusions: Topiramate is a well tolerated and seemingly 
efficient alternative to standard withdrawal treatments for multidrug 
users. 
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Longitudinal study of psychiatric comorbidity in MDMA users 
J.M. Gines, R. Blanco, M. Torrens, R. Martin-Santos, S. Poudevida, 
PN. Rose& M. Farre, R. de la Torre. Institute Municipal de 
Investigation Medica (IMIM), Grup de Recerca en Psiquiatria, 
Unitat de Recerca en Farmacologia, Spain 
Introduction: Prevalence and relationship between psychiatric 
comorbidity and MDMA use is not clearly established. 
Objectives: To study, in a longitudinal case-control design, the 
prevalence of psychiatric disorders in a sample of MDMA users 
non-seeking treatment. 
Subjects: Forty MDMA users non-seeking treatment and 48 
matched controls. 
Methods: All subjects were diagnosed (DSM-IV) in a blind 
manner with the validated Spanish version of a semi-structured in- 
terview specifically designed for substance abuse patients (PRISM, 
1996) 
R&Its at baseline evaluation: 
Twenty-eight percent of cases had the diagnosis of MDMA 
abuse disorder and 13 % had MDMA dependence disorder. Most 
cases showed other substance use disorder (65% cannabis, 28% 
alcohol, 25% cocaine). Only 2% of alcohol abuse was found in 
controls. 
Thirty-two percent of cases had other psychiatric disorder non- 
related to substance use (affective 5%, anxiety 8%, eating 3%). 
Only 6% of controls had non-related to substance use psychiatric 
disorder (affective 2%, anxiety 2%, eating 2%). _ . 
Conclusions: MDMA users non-seeking treatment has a lugher 
prevalence of psychiatric comorbidity than controls. 
P55.05 
Affective disorders and craving to drugs in heroin addiction 
M. Rokhlina’, A. Kozlov, S. Mohnatchev. Research Institute on 
Addiction, Moscow, Russia 
Objectives: the affective disorders are the frequent psychopathol- 
ogy caused by drug abuse. Being a clinical manifestation an 
affective disturbances are. frequently included into pathological 
pattern of craving to drugs. 
Methods: 129 heroin addicts (99 men and 30 women) aged from 
17 to 36 years old have been examined. Duration of drug misuse 
varied from 6 months to 6 years. 
Results: in the first stage of withdrawal syndrome (5-7 days 
after the last heroin intake) affective disorders were accompanied 
by somato-vegetative and algesic symptoms. These disturbances 
become most prominent after cessation of acute withdrawal symp- 
toms. There were predominant astheno-depressive, anxious and 
dysphoric symptoms with behavioral difficulties in the structure 
of these disturbances. The aggravation of depression with the 
typical dysphoric features normally indicated to the actualization 
of pathological craving to the narcotics and needs the treatment. 
Considering the structure of affective disorders we preferred to ad- 
ministrate medications both with thymoleptic and sedative activity. 
Antidepressants were combined with mild neuroleptics. 
Conclusions: clear association between severity of depressive 
disorders and intensity of craving to drugs was found. Adminis- 
tration of antidepressants is obligatory in the treatment of heroin 
addiction. 
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Gambling co-morbidity in heroin addicts in MMT 
M. Campana’, M. Metzger, M. Riglietta, L. Tidone. Department of 
Addictive Behaviours - As1 di Bergamo; 2ECCAS-Network, Italy 
Goals: to evaluate co-morbidity for gambling in a group of heroin 
addicted patients (according to DSM IV criteria) in Methadone 
maintenance treatment (MMT) for more than 3 months. 
Methods: we included all the patients in MMT in a defined 
week and we sent to all a letter in order to clarify the goals of the 
research and to collect their informed consent. We used SOGS - 
Gambling History Test (South Oaks Clinical Team by Lesieur & 
Blume - 1987) submitted by a trained professional. 
Results: 
MMT group 715 
MMT group > 3 594 
months 




% 34 % 25 % 
75 19 7.8 42 17.2 
Conclusions: our study shows an interesting result about patho- 
logical gambling in this specific group of patients: 25% of these 
has a significant score (>2) at the SOGS-test. At the present it 
is quite difficult to compare our results because we do not know 
if exist any international data about co-morbidity for gambling in 
addicts. 
These results however confinn that it is necessary to better 
understand the common patterns of different addictive behaviours 
and to investigate the several aspects of the addictions in every 
patient to manage them in the best way The mission of our 
Department clearly defines that every kind of addiction are to study 
and to treat; for the next future we are defining more focused studies 
on this problem and we are developing a specific clinical unit to 
treat pathological gambling. 
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Gender differences among heroin users 
S.O. Mokhnatchev’. Research Institute on Addictions, Moscow, 
Russia 
Background: Wide spread of heroin abuse in Russia in recent years 
makes it necessary to study and understand gender differences 
among heroin users. 
